Cardiovascular effects of intracerebroventricular d-, l- and dl-propranolol in the conscious rabbit
Related Experiment Videos
The Journal of Pharmacology and Experimental Therapeutics
|February 1, 1974
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Concise Guide to PHARMACOLOGY 2013/14: overview.
British journal of pharmacology·2014
Intracellular drug concentrations.
Clinical pharmacology and therapeutics·2013
Metabolism of terbutaline in man and dog.
British journal of clinical pharmacology·2012
Acute effects of varying doses of propranolol upon oxygen haemoglobin affinity in man.
British journal of clinical pharmacology·2012
Lapatinib-induced liver injury characterized by class II HLA and Gilbert's syndrome genotypes.
Clinical pharmacology and therapeutics·2012
Clinical pharmacology in the molecular era.
Clinical pharmacology and therapeutics·2008
The phosphodiesterase 4B inhibitor A33 blocks locomotor stimulation by low doses of ethanol and diazepam.
The Journal of pharmacology and experimental therapeutics·2026
C5aR2 signaling mechanisms via the β-arrestin-dependent pathway observed in microsecond-scale molecular dynamics simulations.
The Journal of pharmacology and experimental therapeutics·2026
Interleukin-37 overexpression enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells in atopic dermatitis by activating autophagy and improving skin barrier dysfunction.
The Journal of pharmacology and experimental therapeutics·2026
From stress cytokine to drug target: The translational landscape of growth differentiation factor 15.
The Journal of pharmacology and experimental therapeutics·2026
Locomotor stimulant and methamphetamine-like interoceptive effects of putative impurity N-ethyl-methamphetamine in rodents: Role of Phase I metabolism.
The Journal of pharmacology and experimental therapeutics·2026
Leucine-rich repeat kinase 2 is involved in the microtubule-mediated regulation of intraocular pressure.
The Journal of pharmacology and experimental therapeutics·2026
Causative factors and outcomes of pyogenic granulomas presenting to a hospital eye clinic.
Clinical & experimental optometry·2026
Meta-Analysis: Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors for Gastroprotection in Patients Receiving Antiplatelet Therapy.
Alimentary pharmacology & therapeutics·2026
Current practices, challenges, and future directions in subcutaneous oncology monoclonal antibody delivery: a qualitative study.
Expert opinion on drug delivery·2026
Ensuring patient rights, safety, and welfare in "compassionate use" of drugs.
Perspectives in clinical research·2026
Pediatric obesity pharmacotherapy: a practical guide for general pediatricians.
Current opinion in pediatrics·2026
Old Drugs, New Targets: Molecular Docking Insights into Repurposing Proton Pump Inhibitors for the TLR4/MD-2, NLRP3, and C5aR1 Axes in Autoimmune Liver Diseases.
Pharmaceuticals (Basel, Switzerland)·2026